2158-02-3 | Morpholine-4-carboxamide

2158-02-3    1530-89-8 

[1]Schroth,W.;Kluge,H.;Frach,R.;Hodek,W.;Schaedler,H.D.[JournalfurpraktischeChemie(Leipzig1954),1983,vol.325,#5,p.787-802]

[2]Schroth,Werner;Kluge,Helmut;Matthias,Michael;Krieg,Reimar;Schaedler,Hans-Dieter[ZeitschriftfurChemie,1981,vol.21,#1,p.25-27]

2158-02-3    87005-15-0    265107-05-9 

[1]BioorganicandMedicinalChemistry,2005,vol.13,p.3705-3720

110-91-8    1103738-17-5    2158-02-3 

[1]Patent:US2012/172320,2012,A1

2158-02-3    13089-11-7   

methyl3,3,3-trifluoro-2-(morpholin-4-ylcarbonyl)iminopropanoate 

[1]Aksinenko,AlexeyYu.;Goreva,TatyanaV.;Epishina,TatyanaA.;Trepalin,SergeyV.;Sokolov,VladimirB.[JournalofFluorineChemistry,2017,vol.201,p.19-23]

1530-89-8    2158-02-3 

[1]Álvarez,Daniel;Cadierno,Victorio;Crochet,Pascale;González-Fernández,Rebeca;López,Ramón;Menéndez,M.Isabel[Catalysisscienceandtechnology,2020,vol.10,#12,p.4084-4098]

Title: Synthesis, antitumor, antitrypanosomal and antileishmanial activities of benzo[4,5]canthin-6-ones bearing the N'-(Substituted benzylidene)-carbohydrazide and N-Alkylcarboxamide groups at C-2.

Journal: Chemical & pharmaceutical bulletin 20120101

Title: Asymmetric synthesis of (+)-galbelgin, (-)-kadangustin J, (-)-cyclogalgravin and (-)-pycnanthulignenes A and B, three structurally distinct lignan classes, using a common chiral precursor.

Journal: The Journal of organic chemistry 20110819

Title: New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.

Journal: PloS one 20110101

Title: Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs.

Journal: PloS one 20110101

Title: The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.

Journal: International journal of endocrinology 20110101

Title: Structural insights into substrate specificity in variants of N-acetylneuraminic Acid lyase produced by directed evolution.

Journal: Journal of molecular biology 20101119

Title: In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100911

Title: BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080401

Title: Lewis base activation of Lewis acids: catalytic, enantioselective vinylogous aldol addition reactions.

Journal: The Journal of organic chemistry 20070720

Title: Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.

Journal: Calcified tissue international 20070101

Title: Lewis base activation of Lewis acids. Vinylogous aldol addition reactions of conjugated N,O-silyl ketene acetals to aldehydes.

Journal: Journal of the American Chemical Society 20060201

Title: Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.

Journal: Journal of medicinal chemistry 20040408

Title: Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.

Journal: British journal of pharmacology 20030601

Title: BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.

Journal: FEBS letters 20030211

Title: Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.

Journal: Journal of medicinal chemistry 20010802

Title: Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.

Journal: Journal of cellular biochemistry 20010101